Dec 17 2010
More on Dabigatran and Rivaroxaban
Here is a link to a Heartwire summary of 2010 clinical trial reports on dabigatran (Pradaxa, Boehringer-Ingelheim) and rivaroxaban (Xarelto, Bayer and Johnson & Johnson), with some descriptions of progress in development of additional oral antithrombotics.
read more